Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients

By sjmartinez • June 9, 2023

Taus E, Shino MY, Ibarrondo FJ, Hausner MA, Hofmann C, Yang OO. Predominantly defective CD8⁺ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients. J Transl Med. 2023 Jun 8;21(1):374. doi: 10.1186/s12967-023-04234-z. PMID: 37291575.

Tags: cellular immunity, COVID-19 mRNA vaccine, Infectious Diseases, Lung transplantation, Publications, Pulmonary, Critical Care & Sleep Medicine, SARS-CoV-2, solid organ transplantation

Related Posts

Healthcare provider and health system leader perspectives on barriers to hypertension care in Malawi: insights from integrated and non-integrated HIV care settings

Hagstrom C, Kalande P, Aryal A, Phiri K, van Oosterhout JJ, Talama G, Lungu E, Phiri S, Moucheraud C, Hoffman R. Healthcare provider and health[...]

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2–LTR Circles Over 12 Weeks

Reed JC, Hall L, McKhann A, Kwak G, Goecker EA, Coombs RW, Chen H, Roa J, Vecchio A, Daar ES, Hunt PW, Marra CM, Campbell[...]

Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns

Zhang TH, Shi Y, Komarova NL, Wodarz D, Kostelny M, Gonzales A, Abbaali I, Chen H, Bresson-Tan G, Dimapasoc M, Harvey W, Oh C, Carmona[...]